J9024
HCPCSInj atezolizumb 5mg hya-tqjs
Official HCPCS Level II long descriptor
Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
HCPCS Level II code J9024 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj atezolizumb 5mg hya-tqjs
Added to HCPCS: 2025-04-01
Nearby codes in J9
- J9000Doxorubicin hcl injection
- J9003Leupro inj, camcevi etm, 1mg
- J9011Datopotamab deruxtecan, 1 mg
- J9015Aldesleukin injection
- J9017Arsenic trioxide injection
- J9021Inj, aspara, rylaze, 0.1 mg
- J9022Inj, atezolizumab,10 mg
- J9023Injection, avelumab, 10 mg
- J9025Azacitidine injection
- J9026Inj, tarlatamab-dlle, 1 mg
- J9027Clofarabine injection
- J9028Inj, nogapendekin pmln, 1mcg
- J9029Instill adstiladrin, tx dose
- J9030Bcg live intravesical 1mg
- J9032Injection, belinostat, 10mg
- J9033Inj, bendamustine hcl, 1mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.